CTR Coding Break – SSDI Version 2.0 Clarifications & Updates

Oncology Coding Break

Published/Updated Date: February 25, 2021

[su_youtube url=”https://youtu.be/Oci9agceSpI”]

The February 2021 Registry Partners CTR Coding Break discusses clarifications and updates with the new SSDI version 2.0. The timing for recording lab tests is now listed as the first criteria within the general instructions. All lab values must be done no earlier than approximately three months before diagnosis and two prostate PSA lab value examples are provided. The new note 3 for the circumferential radial margin (CRM) is reviewed emphasizing surgery of the primary site must be coded within the 30-80 surgical range for colon primaries and 27, 30-80 range for rectal primaries in relation to the CRM. In addition, the code table changes for the Lung SSDI visceral and parietal pleural invasion are noted with the codes 1, 2, and 3 being removed from the coding table. PL 1 and PL 2 are now both included in code 4 and PL 3 is now included in code 5. Finally, the new section on the priority for consult reports is addressed with an example.

Click here if you would like to download this month’s video as a PDF.

Related

Oncology Coding Break – Surgical Margins of the Primary Site

Oncology Coding Break – Surgical Margins of the Primary Site

https://youtu.be/i76sHRlM_Ec The Surgical Margins of the Primary Site describe the final status of margins following the resection of the primary tumor. This data item is an important quality measure for pathology reporting, contributes to staging, and serves as a...

Oncology Coding Break – Pancreatic Cancer: Surgical Insights

Oncology Coding Break – Pancreatic Cancer: Surgical Insights

https://youtu.be/2PsgJKj3lfw In this session of the Oncology Coding Break, we focus on surgical resections for pancreatic cancer. Anatomy is reviewed to help us be knowledgeable of what may be excised during a pancreatic surgery. The pancreas has 3 main sections...

Stay in Touch

Get our latest articles, registry insights, and company news straight to your inbox.

This field is for validation purposes and should be left unchanged.